Table 2.
Research agenda
Education | |
○ Establishment of consensual training requirements | |
○ Development of a training framework and practical opportunities | |
Clinical applications | |
○ Development and implementation of synovial tissue biomarkers for diagnosis or prognosis for RMDs in clinical practice | |
Translational research | |
○ Synovial tissue atlas (multi-omics approach) in RMDs | |
○ Assessment of tissular miRNA signature through single-cell approaches (single-cell miRNome) in RMDs | |
Quality appraisal of research | |
○ EULAR points to consider for minimal reporting requirements in synovial tissue clinical practice and research in rheumatology | |
Therapy | |
○ Personalized medicine and sequential therapy in RMDs | |
○ Synovial cells reprogramming |